RI
CNTB

RTW Investments’s Connect Biopharma Holdings CNTB Stock Holding History

RTW Investments’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-446,564
Closed -$1.35M – 111
2022
Q1 		$1.35M Sell
446,564
-3,436
-0.8% -$14.5K 0.03% 94
2021
Q4 		$2.32M Hold
450,000
– – 0.03% 106
2021
Q3 		$10.9M Hold
450,000
– – 0.16% 76
2021
Q2 		$8.79M Hold
450,000
– – 0.13% 78
2021
Q1 		$8.32M Buy
+450,000
New +$7.66M 0.13% 76

Other funds holding CNTB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

RTW Investments's CNTB Position: Q2 2022 in Review

RTW Investments sold out of Connect Biopharma Holdings (CNTB) in Q2 2022, closing a stake of 446,564 shares — an estimated $1.35M sold.

RTW Investments first reported a position in CNTB in Q1 2021 and held it in 5 quarters. The position peaked at $10.9M in Q3 2021. 29 funds tracked by Wall St. Rank hold CNTB as of Q2 2022.

  • RTW Investments reported no remaining Connect Biopharma Holdings position as of Q2 2022 after selling out during the quarter.
  • RTW Investments sold 446,564 Connect Biopharma Holdings shares in Q2 2022, an estimated $1.35M.
  • RTW Investments first reported a position in Connect Biopharma Holdings in Q1 2021 and held it in 5 quarters.
  • RTW Investments's Connect Biopharma Holdings position peaked at $10.9M in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2022.

Based on RTW Investments's 13F filing for Q2 2022, filed 15 Aug 2022.